Order Article Reprints

Ceballos-Gutiérrez A, Rodríguez-Hernández A, Álvarez-Valadez MdR, Limón-Miranda S, Andrade F, Figueroa-Gutiérrez A, Díaz-Reval I, Apolinar-Iribe A, Castro-Sánchez L, Alamilla J, et al. ZnO Nanoparticles Induce Dyslipidemia and Atherosclerotic Lesions Leading to Changes in Vascular Contractility and Cannabinoid Receptors Expression as Well as Increased Blood Pressure. Nanomaterials. 2021; 11(9):2319. https://doi.org/10.3390/nano11092319

Ceballos-Gutiérrez, Adriana, Alejandrina Rodríguez-Hernández, María del Rosario Álvarez-Valadez, Saraí Limón-Miranda, Felipa Andrade, Alejandro Figueroa-Gutiérrez, Irene Díaz-Reval, Alejandro Apolinar-Iribe, Luis Castro-Sánchez, Javier Alamilla, and et al. 2021. "ZnO Nanoparticles Induce Dyslipidemia and Atherosclerotic Lesions Leading to Changes in Vascular Contractility and Cannabinoid Receptors Expression as Well as Increased Blood Pressure" Nanomaterials 11, no. 9: 2319. https://doi.org/10.3390/nano11092319

Ceballos-Gutiérrez, A., Rodríguez-Hernández, A., Álvarez-Valadez, M. d. R., Limón-Miranda, S., Andrade, F., Figueroa-Gutiérrez, A., Díaz-Reval, I., Apolinar-Iribe, A., Castro-Sánchez, L., Alamilla, J., Sánchez-Pastor, E., & Virgen-Ortiz, A. (2021). ZnO Nanoparticles Induce Dyslipidemia and Atherosclerotic Lesions Leading to Changes in Vascular Contractility and Cannabinoid Receptors Expression as Well as Increased Blood Pressure. Nanomaterials, 11(9), 2319. https://doi.org/10.3390/nano11092319